Article Text

Download PDFPDF

Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China
  1. Xiaopei Chao,
  2. Lei Li,
  3. Ming Wu,
  4. Shuiqing Ma,
  5. Xianjie Tan,
  6. Sen Zhong,
  7. Jinghe Lang,
  8. Aoshuang Cheng,
  9. Wenhui Li
  1. Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China
  1. Correspondence to Dr Lei Li; lileigh{at}163.com

Abstract

Introduction In the last three decades, minimally invasive surgery (MIS) for radical hysterectomy (RH) has become a popular treatment option for early-stage cervical cancer. However, a recently published randomised controlled trial (LACC trial) and an epidemiological study in the USA revealed strong evidence against the survival advantage of MIS for RH. However, the influencing factors of research centres and the learning curves of surgeons in these studies lacked sufficient evaluation. The efficacy of different surgical approaches for early-stage cervical cancer in the clinical and survival outcomes remains to be validated.

Methods and analysis Patients diagnosed with FIGO (2009) stage IA1 (with lymphovascular space invasion), IA2 or IB1 cervical cancer with histological subtype of squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma will be recruited in this multicentre randomised controlled study. Patients will be randomly assigned to undergo MIS (robot-assisted or laparoscopic RH) or abdominal RH. Within 2 years, 1448 patients in 28 centres in China will be recruited to meet the criteria of a non-inferiority threshold of HR of 1.6 with bilateral nominal α <0.05 and power of 0.8. All surgeries will be performed by the indicated experienced surgeons. At least 100 RH cases in the individual past one decade of practice will be analysed as proof of learning curves. The primary objective of this study is 5-year disease-free survival. The secondary objectives include the overall survival rate, progression-free survival rate, disease-free survival rate, cost-effectiveness and quality of life.

Ethics and dissemination This study has been approved by the Institutional Review Board of Peking Union Medical College Hospital and is filed on record by all other centres. Written informed consent will be obtained from all eligible participants before enrolment. The results will be disseminated through community events, academic conferences, student theses and peer-reviewed journals.

Trial registration number NCT03739944.

  • cervical cancer
  • laparoscopy
  • abdominal surgery
  • disease-free survival
  • learning curve
  • radical hysterectomy

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors LL and MW conceived of the original idea for the study, carried out the statistical analysis, edited the paper and were overall guarantors. XC obtained ethical approval, contributed to the preparation of the data set and contributed to drafts of the paper. SM, XT, SZ, JL, AC and WL contributed to the study design, interpretation of results and commented on drafts of the paper.

  • Funding This work is supported by the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (CAMS-2017-I2M-1-002).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This study has been approved by the Institutional Review Board of Peking Union Medical College Hospital (registration no. JS-1712) and filed on record by all other centres.

  • Provenance and peer review Not commissioned; externally peer reviewed.